Schryver Medical Sales and Marketing, a portfolio company of Revelstoke Capital Partners, has completed the acquisitions of Main Street Clinical Laboratory and On-Site Imaging Solutions. These two acquisitions follow Schryver’s January 2015 acquisition of Nashville-based Quality Mobile X-Ray.
Main Street Clinical Laboratory is a CLIA certified clinical laboratory that provides a test menu of laboratory services to physicians and other healthcare providers. The Clinical Laboratory Improvement Amendments of 1988 (CLIA) regulations include federal standards that are applicable to all US facilities that test human specimens for health assessment or to diagnose, prevent, or treat disease. Main Street’s service area includes Mississippi, Tennessee and Arkansas. Main Street Clinical Laboratory is based south of Memphis in Southaven, MS (www.mainstreetlab.com).
On-Site Imaging Solutions provides mobile imaging to nursing homes, healthcare facilities, hospice centers, correctional facilities and home health patients throughout Arkansas. On-Site also offers EKG, ultrasound, and cardiac imaging services. The company is based in Little Rock, AR (www.myonsiteimaging.com).
Schryver Medical, acquired by Revelstoke in July 2014, is a provider of mobile imaging diagnostics, clinical laboratory services, oxygen therapy and durable medical equipment rental. Schryver serves nearly 3,000 long term post-acute facilities, assisted-living centers, and skilled nursing facilities, as well as numerous homecare patients. The company has approximately 500 employees and is headquartered in Denver (www.schryvermedical.com).
“We are excited to see our operations in the southeastern United States expand,” said Doug Goetz, CEO of Schryver. “Main Street and On-Site are both strategic to our goals and support the momentum we have gained in the southeast. These transactions serve as important steps in our continued effort to grow the Schryver footprint and offer services at a national level.”
“The resources, expertise, and strategy that Schryver has leveraged in building its reputation as a market leader will translate into continued success,” said Mark King, CEO, Managing Partner and Co- Founder of Revelstoke. “We are pleased by the Schryver team’s continued ability to identify and integrate add-on opportunities.”
Revelstoke invests from $10 million to $250 million in companies that have at least $5 million of EBITDA. Sectors of interest include healthcare services and products; transportation and logistics; specialty distribution; energy and energy services; building products; business and outsourced services; marketing services; financial services; industrial services; and medical technology. The firm was founded by Managing Partners – Mark King, Dale Meyer, and Simon Bachleda – and is headquartered in Denver (www.revelstokecp.com).
© 2015 PEPD • Private Equity’s Leading News Magazine • 7-21-15